Implementation of PPACA; Monitor legislation related to medicare and advise client as it affects them.
Implementation of PPACA.
Patent and Trademark Office Fee Modernization Act.
HR4213, American Jobs and Closing Tax Loopholes Act.
Duration: November 1, 2007
to
June 30, 2010
General Issues: Medicare/Medicaid , Health Issues , Copyright/Patent/Trademark , Taxation/Internal Revenue Code , Trade (Domestic & Foreign) , Medical/Disease Research/Clinical Labs
Spending: about $680,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2007: House of Representatives, U.S. Senate,, U.S. Senate, Commerce - Dept of (DOC),, Health & Human Services - Dept of (HHS), White House Office, Commerce - Dept of (DOC), Y
Y
Department of Health and Human Services; White House; House of Representatives; Senate, Y
Y
White House; Department of Health and Human Services; House of Representatives; Senate
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Cecil Swamidoss Legal Intern, US Seante Special Cmte on Aging
(1998); Deputy Investigator, US Sen. Spec. Cmte on
Aging (1999-2001); Investigative Counsel, US Sen
Cmte on Finance (2001); Investigative Counsel, US
Sen Spec. Cmte on Aging (2001-2003); Senior
Counsel, US Sen. Spec. Cmte on Aging (2004-
2008).
Legal Intern, US Senate Spec. Cmte on Aging
(1998); Depty Inv., US Sen. Spec. Cmte on Aging
(1999-2001); Investigate Counsel, US Sen. Cmte
on Finance (2001); Investigative Counsel, US Sen
Gary Andres n/a
BETH POWER n/a
Darren Willcox n/a
Steve Perry n/a
Cartier Esham n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2010
DUTKO WORLDWIDE, LLC terminated an engagement in which they represented PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA on July 14, 2010.
Original Filing: 300286277.xml
Lobbying Issues
Implementation of PPACA; Monitor legislation related to medicare and advise client as it affects them.
Agencies Lobbied
U.S. House of Representatives
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Patent and Trademark Office Fee Modernization Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
HR4213, American Jobs and Closing Tax Loopholes Act.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2010
In Q1, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on April 5, 2010.
Original Filing: 300254491.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Physician Payments Sunshine Act or 2009 (S301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369). Physician Payments Sunshine Act or 2009 (S301).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2009
In Q4, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on Dec. 31, 2009.
Original Filing: 300226970.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Monitor federal legislation related to Medicare and health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2009
DUTKO WORLDWIDE, LLC amended a lobbying report for representation of PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA in Q42009 on Dec. 31, 2009.
Original Filing: 300226971.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare/Medicaid
Lobbying Issues
Monitor federal legislation related to Medicare and health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). Pharmaceutical import safety legislation. Fair Prescription Drug Competition Act (S. 501) & Preserve Access to Affordable Generics Act (S.369).
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2009
In Q3, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $100,000. The report was filed on Oct. 1, 2009.
Original Filing: 300199916.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In particular: Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned), Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In particular: Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to Medicare and other health care IP issues and advise client as it affects them. In particular, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Pathway for Biosimilars Act (H.R. 1548) & America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2009
In Q2, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $100,000. The report was filed on July 14, 2009.
Original Filing: 300176761.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2009
In Q1, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on April 10, 2009.
Original Filing: 300146043.xml
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548) & American Recovery and Reinvestment Act of 2009 (HR1) as it relates to comparative effectiveness research funding.. Health Care Reform Legislation (to date no specific bills have been introduced). Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
4th Quarter, 2008
In Q4, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on Jan. 14, 2009.
Original Filing: 300118465.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
3rd Quarter, 2008
In Q3, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on Oct. 8, 2008.
Original Filing: 300089251.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
2nd Quarter, 2008
In Q2, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on July 9, 2008.
Original Filing: 300062701.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101), Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization. Pharmaceutical import safety legislation.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Improvements for Patients and Providers Act of 2008 (S 3101)
Medicare Improvements for Patients and Providers Act of 2008 (HR 6331), FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
1st Quarter, 2008
DUTKO WORLDWIDE, LLC amended a lobbying report for representation of PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA in Q12008 on April 10, 2008.
Original Filing: 300034554.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145),Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to health issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to patent reform and other trade issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
1st Quarter, 2008
In Q1, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $60,000. The report was filed on April 8, 2008.
Original Filing: 300033560.xml
Lobbying Issues
Monitor legislation pertaining to Medicare and advise client as it affects them, including Patent Reform Act of 2007 (HR1908/S1145),Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor legislation pertaining to health issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Monitor federal legislation related to patent reform and other health care issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Copyright/Patent/Trademark
Lobbying Issues
Monitor federal legislation related to patent reform and other trade issues and advise client as it affects them including Patent Reform Act of 2007 (HR1908/S1145), Medicare Reform Legislation, FY09 Department of Defense Authorization.
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Trade (Domestic & Foreign)
0th Quarter, 2007
In MM, DUTKO WORLDWIDE, LLC lobbied for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA , earning $75,000. The report was filed on Aug. 3, 2007.
Original Filing: 200045680.xml
Lobbying Issues
Monitor legislation pertaining to health issues and advise client as it affects them
Agencies Lobbied
Y
Y
Department of Health and Human Services; White House; House of Representatives; Senate
Lobbying Issues
Monitor legislation pertaining to health issues and advise client as it affects them.
Agencies Lobbied
Y
Y
White House; Department of Health and Human Services; House of Representatives; Senate
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Monitor legislation pertaining to health issues and advise client as it affects them
Agencies Lobbied
Y
Y
White House; Department of Health and Human Services; House of Representatives; Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...